Transderm-induced psychosis in Parkinson's disease.
Quinn
N
N
D000279:Administration, Cutaneous; D006801:Humans; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D010300:Parkinson Disease / Q000188:drug therapy*; D011605:Psychoses, Substance-Induced / Q000209:etiology*; D012601:Scopolamine / Q000008:administration & dosage / Q000009:adverse effects*; D009626:Terminology as Topic
D018727:Muscarinic Antagonists; D012601:Scopolamine